Le Lézard
Classified in: Covid-19 virus
Subjects: SVY, MAT

The Global Condom Market is expected to grow from USD 4,522.38 Million in 2019 to USD 13,405.31 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 19.85%


NEW YORK, June 12, 2020 /PRNewswire/ -- Condom Market Research Report by Product (Colored Condoms, Edible Condoms, Flavored Condoms, Studded Condoms, and Warming Condoms), by Material (Latex, PU Leather, Polyisoprene, and Polyurethane), by Gender, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19

Read the full report: https://www.reportlinker.com/p05913932/?utm_source=PRN

The Global Condom Market is expected to grow from USD 4,522.38 Million in 2019 to USD 13,405.31 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 19.85%.

Market Segmentation & Coverage:
This research report categorizes the Condom to forecast the revenues and analyze the trends in each of the following sub-markets:

On the basis of Product, the Condom Market is studied across Colored Condoms, Edible Condoms, Flavored Condoms, Studded Condoms, and Warming Condoms.

On the basis of Material, the Condom Market is studied across Latex, PU Leather, Polyisoprene, and Polyurethane.

On the basis of Gender, the Condom Market is studied across Female and Male.

On the basis of Distribution, the Condom Market is studied across Offline and Online.

On the basis of Geography, the Condom Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Condom Market including Ansell, Church & Dwight Co., Inc., Karex Berhad, Mankind Pharma, ORION Versand GmbH & Co. KG, Reckitt Benckiser Group plc, Ritex GmbH, Sir Richard's, and The Female Health Company.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Condom Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Condom Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Condom Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Condom Market?
4. What is the competitive strategic window for opportunities in the Global Condom Market?
5. What are the technology trends and regulatory frameworks in the Global Condom Market?
6. What are the modes and strategic moves considered suitable for entering the Global Condom Market?

Read the full report: https://www.reportlinker.com/p05913932/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: